USRE32947E - Magnetic transcutaneous mount for external device of an associated implant - Google Patents

Magnetic transcutaneous mount for external device of an associated implant Download PDF

Info

Publication number
USRE32947E
USRE32947E US07144011 US14401188A USRE32947E US RE32947 E USRE32947 E US RE32947E US 07144011 US07144011 US 07144011 US 14401188 A US14401188 A US 14401188A US RE32947 E USRE32947 E US RE32947E
Authority
US
Grant status
Grant
Patent type
Prior art keywords
member
means
magnet
coil
signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07144011
Inventor
Kenneth J. Dormer
Gordon L. Richard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Integris Baptist Medical Center Inc
Original Assignee
Baptist Medical Center of Oklahoma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001Means for transferring electromagnetic energy to implants

Abstract

Disclosed is a transcutaneous coupling apparatus comprising a first member subcutaneously positioned in a user of the invention and also comprising a second member positioned supercutaneously, or outside the skin of the user. Rare-earth magnets are associated with the first and second members to magnetically secure the second member with the first member without significantly adversely affecting the user's skin intervening between the first and second members.

Description

BACKGROUND OF THE INVENTION

This invention relates generally to apparatus for coupling a member implanted in a body with a member located outside the body. More particularly, but not by way of limitation, the invention relates to a bio-electronic signal coupling device (such as a hearing aid having a cochlear implant unit and a sound receiving unit) utilizing rare-earth magnets to properly align and secure an external member (such as the sound receiving unit) with an internal member (such as the cochlear implant unit).

In the medical implantable electronic prosthesis field it is necessary to maintain proper alignment between units implanted within the body and units associated therewith but located externally of the body. Specifically, in medical prostheses involving electrical signal transfers, such as hearing aids, it is critical to maintain a proper alignment between the implanted and external units to insure effective signal transfer.

For example, a hearing aid known as an auditory neural prosthesis is used to electrically stimulate a user's auditory nerve directly or within the cochlea thereby to enable recognition of environmental sounds and to improve lip-reading skills. Such a prosthesis includes an internal, subcutaneously located signal receiving unit implanted in the user so that an electrical signal can be conducted to a cochlea of the user. The prosthesis also includes an external sound detecting and transmitting unit located outside the skin of the user.

For the sound detecting and transmitting unit to effectively transmit to the receiving unit electrical signals corresponding to the detected sounds, the sound detecting and transmitting unit must be maintained in proper alignment with the receiving unit. Presently proposed or used devices attempt to maintain alignment by utilizing eyeglass frames specially constructed to carry the sound detecting and transmitting unit. This frame structure has the shortcoming of permitting misalignment between the external and internal units because the eyeglass frames can slip and otherwise become easily moved. Such misalignment decreases, if not totally eliminates, the amplitude of the coupled signal received by the receiving unit. This decrease or loss of signal results in decreased or lost cochlea stimulation which causes frustration in the user of the apparatus because he or she has to continually readjust the eyeglass frames to maintain the apparatus operative. This misalignment also hampers the training, evaluation and use of the prosthesis user.

If the eyeglass frame structure were used with multichannel auditory neural prostheses which are being developed to provide frequency coding of detected sounds, the reliability of such multi-channel devices would be greatly decreased because accurate alignment is critical to insure that each of the plurality of signals transmitted by the transmitter means in the multi-channel transmitter unit is received by the proper receiver means in the implanted multi-channel receiving unit.

Although proper alignment must be maintained in medical apparatus having units located both beneath the surface of the skin and above the skin, it is desirable that there be no mechanical connection which extends through the skin of the user between the internal and external units. Although no mechanical connection, which could rigidly maintain a predetermined distance between the internal and external units so that no compression of the intervening skin occurred, is wanted, neither is there desired a coupling device which adversely affects, such as by compression, the skin extending between the implanted unit and the external unit. Therefore, what is desired is an apparatus which secures the external unit with the internal unit without adversely affecting the intervening tissue.

Although there have been proposed and made medical apparatus having implantable units and external units which need to be coupled or held in alignment by some means, such as the aforementioned type of hearing aid using an eyeglass frame, we do not know of any such apparatus which discloses or suggests our invention as disclosed and claimed hereinbelow.

SUMMARY OF THE INVENTION

The present invention overcomes the above-noted and other shortcomings of the prior art by providing a novel and improved medical apparatus coupling device. This apparatus maintains in proper alignment or desired positional securement a unit which is disposed beneath the surface of the skin of a user and a unit located outside the surface of the user's skin. Furthermore, there is no mechanical connection extending through the user's skin to maintain this alignment. Additionally, this present invention has no known significantly adverse effect on the user's skin extending between the internally located unit and the externally positioned unit.

Broadly, the present invention provides a transcutaneous coupling apparatus comprising a first member positioned subcutaneously, a second member positioned supercutaneously (i.e., outside the skin), and magnet means for magnetically securing the second member to the first member.

The first member includes in preferred embodiments electronic means which can receive an electrical signal or transmit an electrical signal or perform both functions. Likewise, the second member includes in a first embodiment means for transmitting the electrical signal to the receiving first member or in another embodiment includes electronic means for receiving the electronic signal transmitted by the first member. Alternatively, the second member can include means for performing both receiving and transmitting functions.

When the first and second members specifically include receiving and transmitting means, respectively, the transcutaneous coupling apparatus is a bio-electronic signal coupling device for maintaining a desired positional relationship between the first and second members so that the proper transmitting and receiving between the members can occur. In such an embodiment the first member specifically includes a first electrically conductive coil having two ends, each of which is embedded in tissue of the user of the apparatus. The second member in such an embodiment includes a second electrically conductive coil and signal generating means, electrically connected to the second coil, for providing an electrical signal to the second coil so that the signal is transferred by electromagnetic induction transcutaneously to the first coil for electrically stimulating the tissue in which the ends of the first coil are embedded.

The magnet means generally includes a rare-earth element. More particularly, the magnet means includes a first rare-earth magnet associated with the first coil of an embodiment of the first member, and the magnet means also includes a second rare-earth magnet associated with the second coil of an embodiment of the second member, for magnetically coupling with the first rare-earth magnet so that the first and second coils are positioned to achieve electromagnetically inductive coupling. To maintain the first and second members in a predetermined relation, the magnet means further includes a third rare-earth magnet associated with the first coil and a fourth rare-earth magnet, associated with the second coil, for magnetically coupling with the third rare-earth magnet. To achieve the predetermined alignment, the third and fourth magnets have as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of the first and second magnets so that each of the magnets on the first member will be attracted to only one of the magnets located on the second member.

From the foregoing it is a general object of the present invention to provide a novel and improved medical apparatus coupling device. Other and further objects, features and advantages of the present invention will be readily apparent to those skilled in the art when the following description of the preferred embodiments is read in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic illustration and block diagram of a preferred embodiment of the present invention.

FIG. 2 is a sectional side elevational view of a coil assembly of the preferred embodiment of the present invention.

FIG. 3 is an end elevational view of the coil assembly shown in FIG. 2.

FIG. 4 is a schematic and block diagram of the electronic elements of the preferred embodiment of the present invention.

FIG. 5 is a sectional side elevational view of a coil assembly of a second preferred embodiment of the present invention.

.Iadd.FIG. 6 is a block diagram of another preferred embodiment of the present invention. .Iaddend.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION

The medical apparatus coupling device of the present invention provides transcutaneous coupling of a subcutaneously located first member with a supercutaneously (i.e., outside the skin) positioned second member. To describe this invention, specific reference will be made to preferred embodiments of a bio-electronic signal coupling device which assists the hearing of a user of the device. The signal coupling device is particularly a hearing aid 2 schematically illustrated by the block diagram shown in FIG. 1.

The hearing aid 2 includes an internal first member 4 which is designated in FIG. 1 as an internal coil assembly 6. In the preferred embodiment the internal coil assembly 6 is a cochlear implant unit containing electronic receiver means for receiving a transmitted signal. However, it is to be noted that in other embodiments the internal coil assembly 6 can include means for transmitting a signal or means for both receiving and transmitting signals. .Iadd.See, for example, transmitter 48 depicted in FIG. 6. .Iaddend.Units other than signal receiving or transmitting ones can also comprise the first member.

The internal coil assembly 6 is subcutaneously located beneath a layer of tissue 8 which includes the epidermal and dermal layers of the skin of the user of the device when the device is the preferred embodiment hearing aid 2. FIGS. 2 and 4 disclose that the internal coil assembly 6 includes a first electrically conductive coil 10 of wire having two ends embedded in subcutaneous tissue. Specifically, as shown in FIG. 4 a first end or electrode 12 of the coil 10 is inserted in a cochlea of the user and a second end or electrode 14 is inserted in adjacent tissue as a reference electrode. In the preferred embodiment the first coil 10 comprises six hundred turns of 40 AWG copper wire. This wire is wound on a first support member 16 comprising a delrin bobbin 18 placed in a ceramic, pot-type core-half 20. The core-half 20 preferably has a right circular cylindrical shape because a hole having a complementary shape can be readily cut with a circular trephine into the bone in which the internal core assembly 6 is to be inserted.

In addition to the first member 4, the present invention includes a second member 22 which in the preferred embodiment includes signal generating and transmitting means 24 located supercutaneously of the user of the invention. FIG. 1 reveals the means 24 includes a sound detector and signal conditioner means 26 and an external coil assembly 28. .Iadd.In the preferred embodiment depicted in FIG. 6, the second member includes a receiver 50. .Iaddend.

The external coil assembly 28 includes a second electrically conductive coil 29. In the preferred embodiment the second coil 29 includes four hundred turns of 38 AWG copper wire wound on a second support member comprising a delrin bobbin and a ceramic, pot-type core-half similar to the bobbin 18 and core-half 20 shown in FIG. 2 constituting the internal coil assembly 6.

The sound detector and signal conditioner 26 is electrically connected to the second electrically conductive coil 29 and generates an electrical signal which is electromagnetically transferred transcutaneously by the second coil 29 to the first coil 10 for electrically stimulating the subcutaneous tissue (specifically, the cochlea) in which the electrodes 12 and 14 of the first coil 10 are embedded. FIG. 4 shows the sound detector and signal conditioner means 26 includes a transducer, specifically a microphone 30, for detecting a sound and converting it into a proportional electrical signal. The proportional electrical signal is amplified by amplifier means 32 and input into amplitude modulation circuit means 34. The amplitude modulation circuit means 34 utilizes the amplified electrical signal to modulate a carrier signal which is generated by carrier frequency generator means 36. In the preferred embodiment the carrier frequency generator means 36 provides a 16 kHz carrier signal which is amplitude modulated by the electrical signal coming from the amplifier means 32. The resultant amplitude modulated signal is provided to the second coil 29 for electromagnetic transmission transcutaneously through the intervening tissue 8 to the first coil 10. The microphone 30, amplifier means 32, amplitude modulation circuit means 34 and carrier frequency generator means 36 depicted in FIG. 4 are of the type as are known in the art.

For the electromagnetically inductive transmission between the first coil 10 and the second coil 29 to be properly achieved, it is necessary to provide means for properly securing the external coil assembly 28 (and the sound detector and signal conditioner means 26 if it is unistructurally combined with the external coil assembly 28) with the internal assembly 6 without significantly adversely affecting the intervening tissue 8. This is achieved in the present invention with magnet means for magnetically securing the second member 22 with the first member 4. The magnet means electromagnetically associates the receiver means provided by the preferred embodiment internal coil assembly 6 with the transmitter means provided by the preferred embodiment means 24 so that the first coil 10 of the receiver means is responsive to the transmitted electrical signal transmitted by the second coil 29 of the preferred embodiment transmitter means. .Iadd.For the FIG. 6 embodiment, the magnet means, comprising two magnets 52, 54, magnetically secures the transmitter 48 and the receiver 50. .Iaddend.

In the preferred embodiment receiver means or internal coil assembly 6 shown in FIG. 2 the magnet means include a rare-earth element which is particularly a first rare-earth magnet 38 associated with the first coil 10 by being concentrically positioned therewith in the pot-type core-half 20. The rare-earth element included within the magnet means may be any appropriate one of the group of chemical elements including atomic numbers between 58 and 71. In the preferred embodiment the rare-earth element is samarium which is combined with cobalt to provide a samarium-cobalt magnet (e.g., SmCo5) having a long magnetic stability and a large maximum energy product.

In addition to the first rare-earth magnet 38 forming a part of the magnet means of the present invention, there is a second rare-earth magnet associated with the second coil 29 of the second member 22 for magnetically coupling with the first rare-earth magnet 38 so that the first and second coils 10 and 29 are positioned for electromagnetically inductive coupling. The magnetic coupling arises by placing attractive poles of the first and second magnets toward each other so that the magnetic lines of force extend through the intervening tissue 8 to retain the internal and external coil assemblies in alignment adjacent the intervening skin. For example, the magnetic north pole of the first rare-earth magnet 38 can be positioned within the first member 4 (specifically, within the core-half 20) so that it lies closer to the second member 22 (specifically, the core-half of the external coil assembly 28) than does the magnetic south pole of the first magnet 38. This positioning of the first magnet 38 requires that the magnetic south pole of the second rare-earth magnet be positioned in the second member 22 so that it will magnetically couple with the magnetic north pole of the first magnet when the second member 22 is placed to properly position the second coil 29 relative to the first coil 10.

To use the preferred embodiment of the present invention depicted in FIGS. 1-4, the first member 4 containing the first rare-earth magnet 38 is subcutaneously implanted in the user of the apparatus. During implantation the electrodes 12 and 14 of the first coil 10 are implanted in the respective locations previously described. Next, the second member 22, having the second rare-earth magnet associated therewith, is positioned supercutaneously adjacent the outer surface of the user's skin so that the first and second magnets magnetically secure themselves together thereby properly positioning the first and second coils 10 and 29 for maximum signal transference from the second member 22 to the first member 4.

The signal which is to be transferred from the second member 22 to the first member 4 is obtained by using the transducer or microphone 30 to detect an ambient sound and converting it into a proportional electrical signal, amplifying this signal, and amplitude modulating with this amplified signal the 16 kHz carrier signal generated by the carrier frequency generator means 36. The amplitude modulated signal is transferred to the second coil 29 of the second member 22 for electromagnetically inductive coupling with the first coil 10 of the first member 4. The electromagnetically induced signal received by the first coil 10 is impressed across the reference tissue and cochlea tissue to which the electrodes of the first coil are embedded. This electrical stimulation of the cochlea enhances the hearing and lip-reading skills of the user.

The previously described type of system utilizing the single first coil 10 and the single second coil 29 is known as a single-channel hearing aid because only a single signal is transferred to the user of the apparatus at any one time. However, there are multi-channel devices which are being developed for simultaneously transferring a plurality of signals to permit frequency coding and subsequent frequency analysis of the detected sounds. To insure the proper operation of such multi-channel devices, it is necessary to accurately align the respective transmitting and receiving channels comprising, for example, a plurality of coils similar to those shown in the drawings. The initial alignment and subsequent maintenance of the alignment would be difficult using the preferred embodiment shown in FIGS. 1--4 because with only a single pair of magnets, the first member and second members could rotate whereby respective channels could become misaligned. To prevent misalignment, a plurality of magnets forming a multiple number of magnet pairs can be used as shown in a second preferred embodiment illustrated in FIG. 5. It is to be noted that although the FIG. 5 embodiment is of the single-channel type, it could readily be adapted to a multi-channel type.

The FIG. 5 embodiment discloses a support member 40 and coil assembly 42 similar to that shown in FIGS. 2 and 3. However, the magnet means of the FIG. 5 embodiment is different from that shown in FIG. 2 because two rare-earth magnets are disposed in the support member 40 of FIG. 5. A first rare-earth magnet 44 is magnetically coupled with a second rare-earth magnet (not shown) which is properly situated in a second member which is similar to the second member 22. A third rare-earth magnet 46 shown in FIG. 5 is paired with a fourth rare-earth magnet (not shown) which is properly situated in the second member of the second preferred embodiment. Therefore, the magnets are grouped in attractive magnetic relation between the receiver and transmitter means of the first and second members, respectively.

It is apparent that through the use of the plurality of magnets depicted in FIG. 5, misalignment is less likely to occur once the first and second members are magnetically coupled. However, it is sometimes necessary to orient the first member with respect to the second member in a single, predetermined alignment.

If the two magnets of the first member shown in FIG. 5 has the same polarity orientation and the two magnets of the second member had the same polarity orientation as between themselves but opposite that of the magnets of the first member, the second member could be magnetically coupled to the first member in either of two directions. For example, if each of the magnets 44 and 46 shown in FIG. 5 has its magnetic north pole facing the second member and each of the magnets in the second member had its magnetic south pole facing the first member, the first and second members could be positively related so that either the first and second magnets and the third and fourth magnets were magnetically coupled or the first and fourth magnets and the second and third magnets were magnetically coupled.

To restrict the alignment between the first and second members to a single predetermined position, the first and third rare-earth magnets 44 and 46 can be disposed in the first member so that the two polarities facing the second member are opposite. For example, the first magnet could have its magnetic north pole disposed for coupling with the second member and the third magnet could have its magnetic south pole disposed for coupling with the second member. To complement this pole placement, the second magnet could be disposed in the second member so that its magnetic south pole is disposed for coupling with the first member and the third magnet could be disposed in the second member so that its magnetic north pole is disposed for coupling with the first member. With such magnetic polarities positioned for coupling the first and second members, the first and second members can only be magnetically coupled in a single alignment because coupling will occur only when the first magnet and second magnet are aligned and the third magnet and fourth magnet are aligned. The reverse alignment of the magnets of the first and second members results in similar poles facing each other thereby causing a repulsive force. This can be more generally stated by saying that the third and fourth magnets have as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of the first and second magnets, respectively.

Although the specific embodiments described above disclose either a single pair of magnetic slugs in the shape of small disks located in the centers of symmetrical pot-type core halves or two such pairs of magnetic slugs, it is to be noted that other configurations are also feasible. For example, a ring magnet disposed along the periphery of the pot-type core-half could be used. Likewise, three disk-shaped magnets could be spaced at 120° intervals around each of the first and second members. Still further, a single magnet could be disposed in either the internal member or the external member and a magnetically attractive material, such as a ferromagnetic material, could be placed in the other member so that the attractive material is held in alignment by the single magnet. Other forms of magnet means can likewise be used and yet remain within the scope of the present invention.

It is also to be noted that although the preferred embodiment of the present invention was described with reference to a bio-electronic signal coupling device (more particularly, a hearing aid), the present invention contemplates any medical apparatus having a first member implanted below the surface of the skin of the user and having a second member located externally to the user's skin but transcutaneously coupled to the first member.

Still further, it is to be noted that the term "hearing aid" as used herein is not limited to those devices which amplify sounds, but rather is intended to encompass all suitable devices which assist one in hearing and/or comprehending sound.

Thus, the present invention of a medical apparatus coupling device is well adapted to carry out the objects and attain the ends and advantages mentioned above as well as those inherent therein. While preferred embodiments of the invention have been described for the purpose of this disclosure, numerous changes in the construction and arrangement of parts can be made by those skilled in the art, which changes are encompassed within the spirit of this invention as defined by the appended claims.

Claims (19)

    What is claimed is: .[.1. A transcutaneous coupling apparatus, comprising:
  1. means includes a rare-earth element..]. 3. .[.An apparatus as defined in claim 1, wherein:
    said first member includes electronic means for receiving an electrical signal; and.]..Iadd.A transcutaneous coupling apparatus, comprising:
    a first member positioned subcutaneously;
    a second member positioned supercutaneously; and
    magnet means, cooperating with said first and second members, for magnetically securing said second member to said first member; and wherein .Iaddend.
    said second member includes electronic means for .[.transmitting the electrical signal.]. .Iadd.generating an electromagnetic transmission to activate electrical conduction in said first member; and
    said first member includes electronic means, responsive to said electromagnetic transmission, for electrically stimulating subcutaneous
  2. tissue.Iaddend.. 4. An apparatus as defined in claim 3, wherein said
  3. magnet means includes a rare-earth element. 5. .[.An apparatus as defined in claim 1, wherein:.]. .Iadd.A transcutaneous coupling apparatus, comprising:
    a first member positioned subcutaneously;
    a second member positioned supercutaneously; and
    magnet means, cooperating with said first and second members, for magnetically securing said second member to said first member; and wherein .Iaddend.
    said first member includes electronic means for .[.transmitting an electrical signal.]. .Iadd.generating an electromagnetic transmission to activate electrical conduction in said second member.Iaddend.; and
    said second member includes electronic means .[.for receiving the electrical signal.]. .Iadd., responsive to said electromagnetic
  4. transmission, for conducting an electrical signal.Iaddend.. 6. An apparatus as defined in claim 5, wherein said magnet means includes a
  5. rare-earth element. 7. .[.An apparatus as defined in claim 1, wherein:.]. .Iadd.A transcutaneous coupling apparatus, comprising:
    a first member positioned subcutaneously;
    a second member positioned supercutaneously; and
    magnet means for magnetically securing said second member to said first member; and wherein .Iaddend.
    said transcutaneous coupling apparatus is a bio-electronic signal coupling device;
    said first member includes:
    a first electrically conductive coil having two ends, each of said two ends being embedded in subcutaneous tissue; and
    said second member includes:
    a second electrically conductive coil; and
    signal generating means, electrically connected to said second coil, for providing an electrical signal to said second coil so that said signal is electromagnetically transferred transcutaneously to said first coil for
  6. electrically stimulating the subcutaneous tissue. 8. An apparatus as defined in claim 7, wherein said magnet means includes a rare-earth
  7. element. 9. An apparatus as defined in claim 7, wherein said magnet means includes:
    a first rare-earth magnet associated with said first coil; and
    a second rare-earth magnet, associated with said second coil, for magnetically coupling with said first rare-earth magnet so that said first and second coils are positioned to achieve electromagnetically inductive
  8. coupling. 10. An apparatus as defined in claim 9, wherein said magnet means further includes:
    a third rear-earth magnet associated with said first coil; and
    a fourth rare-earth magnet, associated with said second coil, for magnetically coupling with said third rare-earth magnet, said third and fourth magnets having as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of said first and second
  9. magnets, respectively. 11. A hearing .[.air.]. .Iadd.aid.Iaddend., comprising:
    sound detector means for detecting sound and converting it into an electrical signal;
    transmitter means, positioned on the ouside of the skin of a user of said hearing aid, for transmitting the electrical signal;
    receiver means, positioned beneath the skin of the user, for receiving the transmitted electrical signal .Iadd.and for conducting said signal into tissue beneath the skin of the user.Iaddend.; and
    magnet means for coupling said transmitter means with said receiver means.Iadd., .Iaddend..[.so that.]. .Iadd.with .Iaddend.said transmitter means and said receiver means .[.are.]. on opposite sides of the surface of the skin of the user.Iadd., so that electrical conduction is activated in said receiver means and from said receiver means into tissue beneath the skin of the user in response to said transmitter means transmitting
  10. the electrical signal.Iaddend.. 12. A hearing aid as defined in claim 11,
  11. wherein said magnet means includes a rare-earth element. 13. .[.A hearing aid as defined in claim 12, wherein:.]. .Iadd.A hearing aid, comprising:
    sound detector means for detecting sound and converting it into an electrical signal;
    transmitter means, positioned on the outside of the skin of a user of said hearing aid, for transmitting the electrical signal;
    receiver means, positioned beneath the skin of the user, for receiving the transmitted electrical signal;
    magnet means for coupling said transmitter means with said receiver means so that said transmitter means and said receiver means are on opposite sides of the surface of the skin of the user; and wherein:
    said magnet means includes a rare-earth element; .Iaddend.
    said receiver means includes a first electrically conductive coil;
    said transmitter means includes a second electrically conductive coil, said first and second coils being electromagnetically associated by said magnet means so that said first coil is responsive to the transmitted electrical
  12. signal. 14. A hearing aid as defined in claim 13, wherein said first coil
  13. includes an end embedded in a cochlea of the user. 15. A hearing aid as defined in claim 14, wherein said sound detector means includes:
    transducer means for receiving a sound and converting it to a proportional electrical signal;
    amplifier means for amplifying the proportional electrical signal;
    carrier generator means for generating a carrier electrical signal; and
    amplitude modulation means, responsive to said amplifier means, for modulating the amplitude of the carrier electrical signal and for transferring the modulated carrier electrical signal to said second coil.
  14. 6. A hearing aid as defined in claim 15, wherein:
    said receiver means further includes a first support member having said first coil associated therewith;
    said transmitter means further includes a second support member having said second coil associated therewith; and
    said magnet means includes:
    a first rare-earth magnet associated with said first support member so that a first polarity of said first magnet is positioned closer to said transmitter means than is a second polarity thereof; and
    a second rare-earth magnet associated with said second support member so that a polarity thereof attractive to the first polarity of said first rare-earth magnet is positioned closer to said first magnet than is a
  15. non-attractive polarity thereof. 17. A hearing aid as defined in claim 11, wherein said magnet means includes a plurality of rare-earth magnets, each of said magnets being associated with a respective one of said transmitter means and said receiver means and being grouped in attractive magnetic relation with another one of said magnets associated with the other of said transmitter means and said receiver means so that said transmitter means and said receiver means are magnetically coupled in a predetermined
  16. alignment. 18. A hearing aid, comprising:
    sound detector means for detecting sound and for converting it into an electrical signal;
    a first electrically conductive coil having a first end embedded in the body tissue of a user of said hearing aid and having a second end embedded in a cochlea of the user;
    a second electrically conductive coil connected to said sound detector means and positioned outside the skin of the user;
    a first rare-earth magnet associated with said first coil; and
    a second rare-earth magnet, associated with said second coil, for magnetically coupling with said first rare-earth magnet so that said first and second coils are positioned to achieve electromagnetically inductive
  17. coupling. 19. A hearing aid as defined in claim 18, further comprising:
    a third rare-earth magnet associated with said first coil; and
    a fourth rare-earth magnet, associated with said second coil, for magnetically coupling with said third rare-earth magnet, said third and fourth magnets having as their attractive polarities magnetic poles of opposite polarities to the attractive polarities of said first and second
  18. magnets, respectively. 20. A method of .[.transcutaneously.]. coupling .[.an.]. .Iadd.a transcutaneous .Iaddend.apparatus having an implantable .Iadd.electrical .Iaddend.member and an external .Iadd.electrical .Iaddend.member, comprising the steps of:
    associating a first rare-earth magnet with the implantable .Iadd.electrical .Iaddend.member;
    associating a second rare-earth magnet with the external .Iadd.electrical .Iaddend.member;
    subcutaneously implanting the implantable .Iadd.electrical .Iaddend.member with the associated first rare-earth magnet; and
    supercutaneously positioning the external .Iadd.electrical .Iaddend.member and associated second rare-earth magnet .[.so that.]. .Iadd.for magnetically securing .Iaddend.the second rare-earth magnet .[.is magnetically secured.]. with the first rare-earth magnet .Iadd.so that electrical conduction occurs within the implantable electrical member and electrical stimulation of subcutaneous tissue results therefrom in response to electromagnetic transmission from the external electrical
  19. member to the implantable electrical member.Iaddend.. 21. A method as defined in claim 20, further comprising the steps of:
    associating, prior to the step of subcutaneously implanting the implantable .Iadd.electrical .Iaddend.member, a third rare-earth magnet with the implantable .Iadd.electrical .Iaddend.member in opposing magnetic polarity relation with the first rare-earth magnet; and
    associating a fourth rare-earth magnet with the external .Iadd.electrical .Iaddend.member in opposing magnetic polarity relation with the second rare-earth magnet so that the fourth rare-earth magnet is magnetically secured with the third rare-earth magnet during the step of supercutaneously positioning the external .Iadd.electrical .Iaddend.member and so that the external .Iadd.electrical .Iaddend.member and the implanted .Iadd.electrical .Iaddend.member are coupled in a predetermined relation.
US07144011 1980-09-30 1988-01-14 Magnetic transcutaneous mount for external device of an associated implant Expired - Lifetime USRE32947E (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US06192480 US4352960A (en) 1980-09-30 1980-09-30 Magnetic transcutaneous mount for external device of an associated implant
US07144011 USRE32947E (en) 1980-09-30 1988-01-14 Magnetic transcutaneous mount for external device of an associated implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07144011 USRE32947E (en) 1980-09-30 1988-01-14 Magnetic transcutaneous mount for external device of an associated implant

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US06192480 Reissue US4352960A (en) 1980-09-30 1980-09-30 Magnetic transcutaneous mount for external device of an associated implant

Publications (1)

Publication Number Publication Date
USRE32947E true USRE32947E (en) 1989-06-13

Family

ID=26841600

Family Applications (1)

Application Number Title Priority Date Filing Date
US07144011 Expired - Lifetime USRE32947E (en) 1980-09-30 1988-01-14 Magnetic transcutaneous mount for external device of an associated implant

Country Status (1)

Country Link
US (1) USRE32947E (en)

Cited By (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314457A (en) * 1993-04-08 1994-05-24 Jeutter Dean C Regenerative electrical
US5314453A (en) * 1991-12-06 1994-05-24 Spinal Cord Society Position sensitive power transfer antenna
US5545191A (en) * 1994-05-06 1996-08-13 Alfred E. Mann Foundation For Scientific Research Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body
US5549658A (en) * 1994-10-24 1996-08-27 Advanced Bionics Corporation Four-Channel cochlear system with a passive, non-hermetically sealed implant
US5603726A (en) * 1989-09-22 1997-02-18 Alfred E. Mann Foundation For Scientific Research Multichannel cochlear implant system including wearable speech processor
US5876425A (en) * 1989-09-22 1999-03-02 Advanced Bionics Corporation Power control loop for implantable tissue stimulator
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6120676A (en) 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6162611A (en) 1993-12-02 2000-12-19 E. Heller & Company Subcutaneous glucose electrode
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6277148B1 (en) 1999-02-11 2001-08-21 Soundtec, Inc. Middle ear magnet implant, attachment device and method, and test instrument and method
US6348070B1 (en) 1998-04-17 2002-02-19 Med-El Elektromedizinische Gerate Ges.M.B.H Magnetic-interference-free surgical prostheses
US6436028B1 (en) 1999-12-28 2002-08-20 Soundtec, Inc. Direct drive movement of body constituent
US6632229B1 (en) * 1999-08-19 2003-10-14 Yugengaisha Pacs Optica Japan Organ anastomosing apparatus and method
US20040240691A1 (en) * 2003-05-09 2004-12-02 Esfandiar Grafenberg Securing a hearing aid or an otoplastic in the ear
US20050075700A1 (en) * 2003-10-02 2005-04-07 Medtronic, Inc. External power source for an implantable medical device having an adjustable magnetic core and system and method related therefore
US6907130B1 (en) * 1998-02-13 2005-06-14 University Of Iowa Research Foundation Speech processing system and method using pseudospontaneous stimulation
US20060244560A1 (en) * 2002-04-01 2006-11-02 Med-El Elektromedizinische Geraete Gmbh Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics
US7266209B1 (en) 2000-01-05 2007-09-04 David William House Cochlear implants with a stimulus in the human ultrasonic range and method for stimulating a cochlea
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US20080281171A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20090134721A1 (en) * 2002-04-01 2009-05-28 Med-El Elektromedisinische Geraete Gmbh MRI-safe Electro-magnetic Tranducer
US7609061B2 (en) 2007-07-13 2009-10-27 Med-El Elektromedizinische Geraete Gmbh Demagnetized implant for magnetic resonance imaging
US7642887B2 (en) 2002-04-01 2010-01-05 Med-El Elektromedizinische Geraete Gmbh System and method for reducing effect of magnetic fields on a magnetic transducer
US7651460B2 (en) 2004-03-22 2010-01-26 The Board Of Regents Of The University Of Oklahoma Totally implantable hearing system
US20100046778A1 (en) * 2003-05-08 2010-02-25 Crawford Scott A Integrated cochlear implant headpiece
US20100046779A1 (en) * 2003-05-08 2010-02-25 Crawford Scott A Modular speech processor headpiece
US20100076524A1 (en) * 2003-10-02 2010-03-25 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US20100076287A1 (en) * 1998-10-08 2010-03-25 Feldman Benjamin J Small Volume In Vitro Analyte Sensor and Methods of Making
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
WO2010122142A1 (en) * 2009-04-23 2010-10-28 Centre Hospitalier Universitaire De Rouen Subcutaneous device for electrical percutaneous connection
US20110022120A1 (en) * 2009-07-22 2011-01-27 Vibrant Med-El Hearing Technology Gmbh Magnetic Attachment Arrangement for Implantable Device
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8107661B1 (en) 2003-05-08 2012-01-31 Advanced Bionics, Llc Listening device cap
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8414750B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8437966B2 (en) 2003-04-04 2013-05-07 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8512239B2 (en) 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8545261B2 (en) 2009-04-23 2013-10-01 Centre Hospitalier Universitaire De Rouen Electrical connection system between an electrical implanted medical device
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US8639353B2 (en) 2009-04-23 2014-01-28 Centre Hospitalier Universitaire De Rouen Electrical connection device implantable in the human body
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8764621B2 (en) 2011-07-11 2014-07-01 Vascor, Inc. Transcutaneous power transmission and communication for implanted heart assist and other devices
US8774930B2 (en) 2009-07-22 2014-07-08 Vibrant Med-El Hearing Technology Gmbh Electromagnetic bone conduction hearing device
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8852101B2 (en) 2005-12-28 2014-10-07 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8897475B2 (en) 2011-12-22 2014-11-25 Vibrant Med-El Hearing Technology Gmbh Magnet arrangement for bone conduction hearing implant
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9022917B2 (en) 2012-07-16 2015-05-05 Sophono, Inc. Magnetic spacer systems, devices, components and methods for bone conduction hearing aids
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9119010B2 (en) 2011-12-09 2015-08-25 Sophono, Inc. Implantable sound transmission device for magnetic hearing aid, and corresponding systems, devices and components
US9179228B2 (en) 2011-12-09 2015-11-03 Sophono, Inc. Systems devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids
US9210521B2 (en) 2012-07-16 2015-12-08 Sophono, Inc. Abutment attachment systems, mechanisms, devices, components and methods for bone conduction hearing aids
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9258656B2 (en) 2011-12-09 2016-02-09 Sophono, Inc. Sound acquisition and analysis systems, devices and components for magnetic hearing aids
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9295425B2 (en) 2002-04-01 2016-03-29 Med-El Elektromedizinische Geraete Gmbh Transducer for stapedius monitoring
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9420388B2 (en) 2012-07-09 2016-08-16 Med-El Elektromedizinische Geraete Gmbh Electromagnetic bone conduction hearing device
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US9526810B2 (en) 2011-12-09 2016-12-27 Sophono, Inc. Systems, devices, components and methods for improved acoustic coupling between a bone conduction hearing device and a patient's head or skull
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9736601B2 (en) 2012-07-16 2017-08-15 Sophono, Inc. Adjustable magnetic systems, devices, components and methods for bone conduction hearing aids
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9788125B2 (en) 2012-07-16 2017-10-10 Sophono, Inc. Systems, devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9919154B2 (en) 2015-12-18 2018-03-20 Advanced Bionics Ag Cochlear implants having MRI-compatible magnet apparatus and associated methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2402392A (en) * 1941-10-28 1946-06-18 Radio Patents Corp Electromagnetic sound-transmission apparatus
US3061689A (en) * 1957-05-27 1962-10-30 Beltone Hearing Aid Company Hearing aid
US3346704A (en) * 1963-12-27 1967-10-10 Jack L Mahoney Means for aiding hearing
US3557775A (en) * 1963-12-27 1971-01-26 Jack Lawrence Mahoney Method of implanting a hearing aid
US3565073A (en) * 1968-04-15 1971-02-23 Jerry D Giesy Method and means for attaching a body appendage
US3712962A (en) * 1971-04-05 1973-01-23 J Epley Implantable piezoelectric hearing aid
US3764748A (en) * 1972-05-19 1973-10-09 J Branch Implanted hearing aids
US3870832A (en) * 1972-07-18 1975-03-11 John M Fredrickson Implantable electromagnetic hearing aid
US4279256A (en) * 1974-10-09 1981-07-21 Louis Bucalo Nerve stimulation method

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2402392A (en) * 1941-10-28 1946-06-18 Radio Patents Corp Electromagnetic sound-transmission apparatus
US3061689A (en) * 1957-05-27 1962-10-30 Beltone Hearing Aid Company Hearing aid
US3346704A (en) * 1963-12-27 1967-10-10 Jack L Mahoney Means for aiding hearing
US3557775A (en) * 1963-12-27 1971-01-26 Jack Lawrence Mahoney Method of implanting a hearing aid
US3565073A (en) * 1968-04-15 1971-02-23 Jerry D Giesy Method and means for attaching a body appendage
US3712962A (en) * 1971-04-05 1973-01-23 J Epley Implantable piezoelectric hearing aid
US3764748A (en) * 1972-05-19 1973-10-09 J Branch Implanted hearing aids
US3870832A (en) * 1972-07-18 1975-03-11 John M Fredrickson Implantable electromagnetic hearing aid
US4279256A (en) * 1974-10-09 1981-07-21 Louis Bucalo Nerve stimulation method

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
"Cochlear Implant Utilizing Rare Earth Magnets", Dormer et al, Am. Jrnl. Otology, vol. 2, #1, 7/1980.
"Cochlear Implants," by William F. House, M.D., printed in The Annals of Otology, Rhinology & Laryngology, May-Jun., 1976.
"Magnetic and Physical Properties of Commercially Available Rare Earth-Cobalt Permanent Magnets," by H. F. Mildrum et al., 1974.
"Magnetic Continent Colostomy Device," by J. Alexander-Williams et al., printed in British Medical Journal, May, 1977.
"Magnetic Materials as Biological Implants--Criteria for Selection," by Jack Driller et al., 1973.
"Neural Prostheses," by F. Terry Hambrecht, printed in Ann. Rev. Biophys. Bioeng., 1979.
"Nonsuture Microvascular Anastomosis Using Magnet Rings: Preliminary Report," by Yoshiro Obora, M.D. et al., Surg. Neurol., vol. 9, Feb. 1978.
"Preliminary Experience with Lid Magnets for Paralytic Lagophthalmos," by E. N. Hinzpeter et al.
"Rare Earth-Cobalt Magnets in Modern Medicine," by G. Hennig, H. Feustel and K. Hennig, 1975.
Cochlear Implant Utilizing Rare Earth Magnets , Dormer et al, Am. Jrnl. Otology, vol. 2, 1, 7/1980. *
Cochlear Implants, by William F. House, M.D., printed in The Annals of Otology, Rhinology & Laryngology, May Jun., 1976. *
Magnetic and Physical Properties of Commercially Available Rare Earth Cobalt Permanent Magnets, by H. F. Mildrum et al., 1974. *
Magnetic Continent Colostomy Device, by J. Alexander Williams et al., printed in British Medical Journal, May, 1977. *
Magnetic Materials as Biological Implants Criteria for Selection, by Jack Driller et al., 1973. *
Neural Prostheses, by F. Terry Hambrecht, printed in Ann. Rev. Biophys. Bioeng., 1979. *
Nonsuture Microvascular Anastomosis Using Magnet Rings: Preliminary Report, by Yoshiro Obora, M.D. et al., Surg. Neurol., vol. 9, Feb. 1978. *
Preliminary Experience with Lid Magnets for Paralytic Lagophthalmos, by E. N. Hinzpeter et al. *
Rare Earth Cobalt Magnets in Modern Medicine, by G. Hennig, H. Feustel and K. Hennig, 1975. *

Cited By (302)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876425A (en) * 1989-09-22 1999-03-02 Advanced Bionics Corporation Power control loop for implantable tissue stimulator
US5603726A (en) * 1989-09-22 1997-02-18 Alfred E. Mann Foundation For Scientific Research Multichannel cochlear implant system including wearable speech processor
US5609616A (en) * 1989-09-22 1997-03-11 Alfred E. Mann Foundation For Scientific Research Physician's testing system and method for testing implantable cochlear stimulator
US6881551B2 (en) 1991-03-04 2005-04-19 Therasense, Inc. Subcutaneous glucose electrode
US8588881B2 (en) 1991-03-04 2013-11-19 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US6514718B2 (en) 1991-03-04 2003-02-04 Therasense, Inc. Subcutaneous glucose electrode
US8414750B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8741590B2 (en) 1991-03-04 2014-06-03 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8414749B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US5314453A (en) * 1991-12-06 1994-05-24 Spinal Cord Society Position sensitive power transfer antenna
US5314457A (en) * 1993-04-08 1994-05-24 Jeutter Dean C Regenerative electrical
US6284478B1 (en) 1993-12-02 2001-09-04 E. Heller & Company Subcutaneous glucose electrode
US6162611A (en) 1993-12-02 2000-12-19 E. Heller & Company Subcutaneous glucose electrode
US6329161B1 (en) 1993-12-02 2001-12-11 Therasense, Inc. Subcutaneous glucose electrode
US5545191A (en) * 1994-05-06 1996-08-13 Alfred E. Mann Foundation For Scientific Research Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body
US5549658A (en) * 1994-10-24 1996-08-27 Advanced Bionics Corporation Four-Channel cochlear system with a passive, non-hermetically sealed implant
US5749912A (en) * 1994-10-24 1998-05-12 House Ear Institute Low-cost, four-channel cochlear implant
US8123929B2 (en) 1997-02-06 2012-02-28 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US9234864B2 (en) 1997-02-06 2016-01-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8142643B2 (en) 1997-02-06 2012-03-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6143164A (en) 1997-02-06 2000-11-07 E. Heller & Company Small volume in vitro analyte sensor
US6551494B1 (en) 1997-02-06 2003-04-22 Therasense, Inc. Small volume in vitro analyte sensor
US7909984B2 (en) 1997-02-06 2011-03-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6576101B1 (en) 1997-02-06 2003-06-10 Therasense, Inc. Small volume in vitro analyte sensor
US8142642B2 (en) 1997-02-06 2012-03-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6120676A (en) 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US8105476B2 (en) 1997-02-06 2012-01-31 Abbott Diabetes Care Inc. Integrated lancing and measurement device
US7906009B2 (en) 1997-02-06 2011-03-15 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8114271B2 (en) 1997-02-06 2012-02-14 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8114270B2 (en) 1997-02-06 2012-02-14 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8118992B2 (en) 1997-02-06 2012-02-21 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US7988845B2 (en) 1997-02-06 2011-08-02 Abbott Diabetes Care Inc. Integrated lancing and measurement device and analyte measuring methods
US6907130B1 (en) * 1998-02-13 2005-06-14 University Of Iowa Research Foundation Speech processing system and method using pseudospontaneous stimulation
US20060042080A1 (en) * 1998-03-04 2006-03-02 Therasense, Inc. Method of making an electrochemical sensor
US6973706B2 (en) 1998-03-04 2005-12-13 Therasense, Inc. Method of making a transcutaneous electrochemical sensor
US7003340B2 (en) 1998-03-04 2006-02-21 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8136220B2 (en) 1998-03-04 2012-03-20 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US7721412B2 (en) 1998-03-04 2010-05-25 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US8117734B2 (en) 1998-03-04 2012-02-21 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US7879213B2 (en) 1998-03-04 2011-02-01 Abbott Diabetes Care Inc. Sensor for in vitro determination of glucose
US20080287760A1 (en) * 1998-03-04 2008-11-20 Therasense, Inc. method of making an electrochemical sensor
US7996054B2 (en) 1998-03-04 2011-08-09 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8168051B2 (en) 1998-03-04 2012-05-01 Abbott Diabetes Care Inc. Sensor for determination of glucose
US8273227B2 (en) 1998-03-04 2012-09-25 Abbott Diabetes Care Inc. Sensor for in vitro determination of glucose
US7861397B2 (en) 1998-03-04 2011-01-04 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US8706180B2 (en) 1998-03-04 2014-04-22 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6484046B1 (en) 1998-03-04 2002-11-19 Therasense, Inc. Electrochemical analyte sensor
US6348070B1 (en) 1998-04-17 2002-02-19 Med-El Elektromedizinische Gerate Ges.M.B.H Magnetic-interference-free surgical prostheses
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6565509B1 (en) 1998-04-30 2003-05-20 Therasense, Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8262996B2 (en) 1998-10-08 2012-09-11 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8211363B2 (en) 1998-10-08 2012-07-03 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8650751B2 (en) 1998-10-08 2014-02-18 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US8226815B2 (en) 1998-10-08 2012-07-24 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8192611B2 (en) 1998-10-08 2012-06-05 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8187895B2 (en) 1998-10-08 2012-05-29 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8083924B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8186044B2 (en) 1998-10-08 2012-05-29 Abbott Diabetes Care Inc. Method of manufacturing small volume in vitro analyte sensors
US8449758B2 (en) 1998-10-08 2013-05-28 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8182670B2 (en) 1998-10-08 2012-05-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8425758B2 (en) 1998-10-08 2013-04-23 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8268144B2 (en) 1998-10-08 2012-09-18 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8221685B2 (en) 1998-10-08 2012-07-17 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8268163B2 (en) 1998-10-08 2012-09-18 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8701282B2 (en) 1998-10-08 2014-04-22 Abbott Diabetes Care Inc. Method for manufacturing a biosensor
US8272125B2 (en) 1998-10-08 2012-09-25 Abbott Diabetes Care Inc. Method of manufacturing in vitro analyte sensors
US8182671B2 (en) 1998-10-08 2012-05-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8273241B2 (en) 1998-10-08 2012-09-25 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8083928B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US9234863B2 (en) 1998-10-08 2016-01-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US9291592B2 (en) 1998-10-08 2016-03-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8087162B2 (en) 1998-10-08 2012-01-03 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US9891185B2 (en) 1998-10-08 2018-02-13 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8153063B2 (en) 1998-10-08 2012-04-10 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US20100076287A1 (en) * 1998-10-08 2010-03-25 Feldman Benjamin J Small Volume In Vitro Analyte Sensor and Methods of Making
US9316609B2 (en) 1998-10-08 2016-04-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8118993B2 (en) 1998-10-08 2012-02-21 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8083929B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8425743B2 (en) 1998-10-08 2013-04-23 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8372261B2 (en) 1998-10-08 2013-02-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US9341591B2 (en) 1998-10-08 2016-05-17 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8377378B2 (en) 1998-10-08 2013-02-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8163164B2 (en) 1998-10-08 2012-04-24 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8091220B2 (en) 1998-10-08 2012-01-10 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US8728297B2 (en) 1998-10-08 2014-05-20 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6277148B1 (en) 1999-02-11 2001-08-21 Soundtec, Inc. Middle ear magnet implant, attachment device and method, and test instrument and method
US6632229B1 (en) * 1999-08-19 2003-10-14 Yugengaisha Pacs Optica Japan Organ anastomosing apparatus and method
US6436028B1 (en) 1999-12-28 2002-08-20 Soundtec, Inc. Direct drive movement of body constituent
US7266209B1 (en) 2000-01-05 2007-09-04 David William House Cochlear implants with a stimulus in the human ultrasonic range and method for stimulating a cochlea
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8236242B2 (en) 2001-04-02 2012-08-07 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8268243B2 (en) 2001-04-02 2012-09-18 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8765059B2 (en) 2001-04-02 2014-07-01 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US7566296B2 (en) 2002-04-01 2009-07-28 Med-El Elektromedizinische Geraete Gmbh Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics
US20100004716A1 (en) * 2002-04-01 2010-01-07 Med-El Elektromedizinische Geraete Gmbh Reducing Effect of Magnetic and Electromagnetic Fields on an Implant's Magnet and/or Electronics
US20060244560A1 (en) * 2002-04-01 2006-11-02 Med-El Elektromedizinische Geraete Gmbh Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics
US20090134721A1 (en) * 2002-04-01 2009-05-28 Med-El Elektromedisinische Geraete Gmbh MRI-safe Electro-magnetic Tranducer
US7976453B2 (en) 2002-04-01 2011-07-12 Med-El Elektromedizinische Geraete Gmbh Reducing effect of magnetic and electromagnetic fields on an implant's magnet and/or electronics
US9295425B2 (en) 2002-04-01 2016-03-29 Med-El Elektromedizinische Geraete Gmbh Transducer for stapedius monitoring
US8013699B2 (en) 2002-04-01 2011-09-06 Med-El Elektromedizinische Geraete Gmbh MRI-safe electro-magnetic tranducer
US7642887B2 (en) 2002-04-01 2010-01-05 Med-El Elektromedizinische Geraete Gmbh System and method for reducing effect of magnetic fields on a magnetic transducer
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US8029442B2 (en) 2002-11-05 2011-10-04 Abbott Diabetes Care Inc. Sensor inserter assembly
US9980670B2 (en) 2002-11-05 2018-05-29 Abbott Diabetes Care Inc. Sensor inserter assembly
US7582059B2 (en) 2002-11-05 2009-09-01 Abbott Diabetes Care Inc. Sensor inserter methods of use
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8187183B2 (en) 2002-12-31 2012-05-29 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8622903B2 (en) 2002-12-31 2014-01-07 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8682598B2 (en) 2003-04-04 2014-03-25 Abbott Laboratories Method and system for transferring analyte test data
US8437966B2 (en) 2003-04-04 2013-05-07 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8483974B2 (en) 2003-04-04 2013-07-09 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8560250B2 (en) 2003-04-04 2013-10-15 Abbott Laboratories Method and system for transferring analyte test data
US20100046778A1 (en) * 2003-05-08 2010-02-25 Crawford Scott A Integrated cochlear implant headpiece
US8170253B1 (en) 2003-05-08 2012-05-01 Advanced Bionics Listening device cap
US20100046779A1 (en) * 2003-05-08 2010-02-25 Crawford Scott A Modular speech processor headpiece
US8983102B2 (en) 2003-05-08 2015-03-17 Advanced Bionics Ag Speech processor headpiece
US8107661B1 (en) 2003-05-08 2012-01-31 Advanced Bionics, Llc Listening device cap
US8270647B2 (en) 2003-05-08 2012-09-18 Advanced Bionics, Llc Modular speech processor headpiece
US8811643B2 (en) 2003-05-08 2014-08-19 Advanced Bionics Integrated cochlear implant headpiece
US20040240691A1 (en) * 2003-05-09 2004-12-02 Esfandiar Grafenberg Securing a hearing aid or an otoplastic in the ear
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8647269B2 (en) 2003-06-10 2014-02-11 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8512239B2 (en) 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8005547B2 (en) * 2003-10-02 2011-08-23 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US20110022125A1 (en) * 2003-10-02 2011-01-27 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US8165678B2 (en) * 2003-10-02 2012-04-24 Medtronic, Inc. Inductively rechargeable external energy source, charger and system for a transcutaneous inductive charger for an implantable medical device
US9821112B2 (en) 2003-10-02 2017-11-21 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US7286881B2 (en) * 2003-10-02 2007-10-23 Medtronic, Inc. External power source having an adjustable magnetic core and method of use
US8554322B2 (en) 2003-10-02 2013-10-08 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US9463324B2 (en) 2003-10-02 2016-10-11 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US20100076524A1 (en) * 2003-10-02 2010-03-25 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US20050075700A1 (en) * 2003-10-02 2005-04-07 Medtronic, Inc. External power source for an implantable medical device having an adjustable magnetic core and system and method related therefore
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US7651460B2 (en) 2004-03-22 2010-01-26 The Board Of Regents Of The University Of Oklahoma Totally implantable hearing system
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US9775563B2 (en) 2005-09-30 2017-10-03 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9480421B2 (en) 2005-09-30 2016-11-01 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US8852101B2 (en) 2005-12-28 2014-10-07 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9332933B2 (en) 2005-12-28 2016-05-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9795331B2 (en) 2005-12-28 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US8862198B2 (en) 2006-09-10 2014-10-14 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9808186B2 (en) 2006-09-10 2017-11-07 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080281171A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US7609061B2 (en) 2007-07-13 2009-10-27 Med-El Elektromedizinische Geraete Gmbh Demagnetized implant for magnetic resonance imaging
US9066709B2 (en) 2009-01-29 2015-06-30 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8473220B2 (en) 2009-01-29 2013-06-25 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8676513B2 (en) 2009-01-29 2014-03-18 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9993188B2 (en) 2009-02-03 2018-06-12 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9636068B2 (en) 2009-02-03 2017-05-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
FR2944920A1 (en) * 2009-04-23 2010-10-29 Pierre Sabin Subcutaneous device of percutaneous electrical connection
US8639353B2 (en) 2009-04-23 2014-01-28 Centre Hospitalier Universitaire De Rouen Electrical connection device implantable in the human body
CN102428613A (en) * 2009-04-23 2012-04-25 鲁昂大学医学中心 Subcutaneous device for electrical percutaneous connection
WO2010122142A1 (en) * 2009-04-23 2010-10-28 Centre Hospitalier Universitaire De Rouen Subcutaneous device for electrical percutaneous connection
CN102428613B (en) 2009-04-23 2014-09-10 鲁昂大学医学中心 Subcutaneous device for electrical percutaneous connection
US8545255B2 (en) 2009-04-23 2013-10-01 Centre Hospitalier Universitaire De Rouen Subcutaneous device for electrical percutaneous connection
US8545261B2 (en) 2009-04-23 2013-10-01 Centre Hospitalier Universitaire De Rouen Electrical connection system between an electrical implanted medical device
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8774930B2 (en) 2009-07-22 2014-07-08 Vibrant Med-El Hearing Technology Gmbh Electromagnetic bone conduction hearing device
US20110022120A1 (en) * 2009-07-22 2011-01-27 Vibrant Med-El Hearing Technology Gmbh Magnetic Attachment Arrangement for Implantable Device
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9750439B2 (en) 2009-09-29 2017-09-05 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9750444B2 (en) 2009-09-30 2017-09-05 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9215992B2 (en) 2010-03-24 2015-12-22 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9687183B2 (en) 2010-03-24 2017-06-27 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9265453B2 (en) 2010-03-24 2016-02-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9186098B2 (en) 2010-03-24 2015-11-17 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9308303B2 (en) 2011-07-11 2016-04-12 Vascor, Inc. Transcutaneous power transmission and communication for implanted heart assist and other devices
US8764621B2 (en) 2011-07-11 2014-07-01 Vascor, Inc. Transcutaneous power transmission and communication for implanted heart assist and other devices
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9119010B2 (en) 2011-12-09 2015-08-25 Sophono, Inc. Implantable sound transmission device for magnetic hearing aid, and corresponding systems, devices and components
US9526810B2 (en) 2011-12-09 2016-12-27 Sophono, Inc. Systems, devices, components and methods for improved acoustic coupling between a bone conduction hearing device and a patient's head or skull
US9179228B2 (en) 2011-12-09 2015-11-03 Sophono, Inc. Systems devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids
US9258656B2 (en) 2011-12-09 2016-02-09 Sophono, Inc. Sound acquisition and analysis systems, devices and components for magnetic hearing aids
US9931066B2 (en) 2011-12-11 2018-04-03 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9693713B2 (en) 2011-12-11 2017-07-04 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US8897475B2 (en) 2011-12-22 2014-11-25 Vibrant Med-El Hearing Technology Gmbh Magnet arrangement for bone conduction hearing implant
US9615181B2 (en) 2012-07-09 2017-04-04 Med-El Elektromedizinische Geraete Gmbh Symmetric magnet arrangement for medical implants
US9420388B2 (en) 2012-07-09 2016-08-16 Med-El Elektromedizinische Geraete Gmbh Electromagnetic bone conduction hearing device
US9210521B2 (en) 2012-07-16 2015-12-08 Sophono, Inc. Abutment attachment systems, mechanisms, devices, components and methods for bone conduction hearing aids
US9788125B2 (en) 2012-07-16 2017-10-10 Sophono, Inc. Systems, devices, components and methods for providing acoustic isolation between microphones and transducers in bone conduction magnetic hearing aids
US9022917B2 (en) 2012-07-16 2015-05-05 Sophono, Inc. Magnetic spacer systems, devices, components and methods for bone conduction hearing aids
US9736601B2 (en) 2012-07-16 2017-08-15 Sophono, Inc. Adjustable magnetic systems, devices, components and methods for bone conduction hearing aids
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9919154B2 (en) 2015-12-18 2018-03-20 Advanced Bionics Ag Cochlear implants having MRI-compatible magnet apparatus and associated methods

Similar Documents

Publication Publication Date Title
US3449768A (en) Artificial sense organ
US5117825A (en) Closed loop transmitter for medical implant
US6358281B1 (en) Totally implantable cochlear prosthesis
US7324915B2 (en) Data transmission to a position sensor
US5433736A (en) Implantable medical apparatus and extracorporeal programming and control unit therefor
US5762583A (en) Piezoelectric film transducer
US5061282A (en) Cochlear implant auditory prosthesis
US6556870B2 (en) Partially inserted cochlear implant
US5922017A (en) Device and method for implants in ossified cochleas
US20110004278A1 (en) External Charger for a Medical Implantable Device Using Field Sensing Coils to Improve Coupling
US6565503B2 (en) At least partially implantable system for rehabilitation of hearing disorder
US4988333A (en) Implantable middle ear hearing aid system and acoustic coupler therefor
US20060129205A1 (en) Method and system for cortical stimulation with rectangular and/or complex electrical pulses to provide therapy for stroke and other neurological disorders
US5318502A (en) Hearing aid having gel or paste transmission means communcative with the cochlea and method of use thereof
US20060178711A1 (en) Prosthetic hearing implant fitting technique
US5411467A (en) Implantable hearing aid
US4267410A (en) Prosthesis
US5941905A (en) Public alarm for cochlear implant
US20060183965A1 (en) Integrated implantable hearing device, microphone and power unit
US6537200B2 (en) Partially or fully implantable hearing system
US5999856A (en) Implantable hearing assistance system with calibration and auditory response testing
US20040210103A1 (en) Coupling device for a two-part bone-anchored hearing aid apparatus
US20020029070A1 (en) At least partially implantable system for rehabilitation a hearing disorder
US6050933A (en) Hearing aid transducer support
US6001129A (en) Hearing aid transducer support

Legal Events

Date Code Title Description
AS Assignment

Owner name: INTEGRIS BAPTIST MEDICAL CENTER, INC., OKLAHOMA

Free format text: CHANGE OF NAME;ASSIGNOR:BAPTIST MEDICAL CENTER OF OKLAHOMA, INC.;REEL/FRAME:007795/0012

Effective date: 19951218